Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate
about
sameAs
Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysisThe antithrombotic profile of aspirin. Aspirin resistance, or simply failure?Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levelsAspirin resistance: current status and role of tailored therapyIn vitro aspirin resistance detected by PFA-100 closure time: pivotal role of plasma von Willebrand factorA critical appraisal of the phenomenon of aspirin resistanceResistance to antiplatelet drugs: current status and future researchEnhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trialAspirin and clopidogrel resistance: an emerging clinical entityMore on: enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized cross-over trialAspirin resistance: a revival of platelet aggregation tests?Lack of association between gene sequence variations of platelet membrane receptors and aspirin responsiveness detected by the PFA-100 system in patients with coronary artery diseaseUsefulness of whole blood aggregometry and its comparison with thromboxane generation assay in monitoring acetylsalicylic acid effectiveness--a multiparametric study in ratsThe effect of acetylsalicylic acid resistance on prognosis of patients who have developed acute coronary syndrome during acetylsalicylic acid therapyPlatelet function measured by VerifyNow identifies generalized high platelet reactivity in aspirin treated patientsHypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapyCritical Overview on the Benefits and Harms of Aspirin.Pharmacometabolomics reveals that serotonin is implicated in aspirin response variabilityAspirin resistance: Fact or fiction? A point of view.Clinical importance of aspirin and clopidogrel resistanceAspirin and platelet adenosine diphosphate receptor antagonists in acute coronary syndromes and percutaneous coronary intervention: role in therapy and strategies to overcome resistance.Searching for factors associated with resistance to acetylsalicylic acid used for secondary prevention of strokeAldose reductase, oxidative stress, and diabetic mellitus.Circulating primers enhance platelet function and induce resistance to antiplatelet therapy.Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function.Thrombelastography: current clinical applications and its potential role in interventional cardiology.Non-compliance is the predominant cause of aspirin resistance in chronic coronary arterial disease patientsAspirin and clopidogrel response variability: review of the published literatureDiabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularizationAspirin resistance: disparities and clinical implications.Static platelet adhesion, flow cytometry and serum TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease: a randomised cross-over studyAspirin resistance: A fact or a myth?Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting.Monitoring antiplatelet therapy with point-of-care platelet function assays: a review of the evidence.Resistance to acetylsalicylic acid in patients with type 2 diabetes mellitus is associated with lipid disorders and history of current smokingReview article: Diabetes mellitus and heart failure--an overview of epidemiology and management.Purine pathway implicated in mechanism of resistance to aspirin therapy: pharmacometabolomics-informed pharmacogenomics.Dosing strategies for antiplatelet therapy in percutaneous coronary intervention.Diagnosis and treatment of platelet hyperactivity in relation to thrombosis in dogs and cats.Overcoming aspirin treatment failure in diabetes.
P2860
Q24645413-2995D3AF-6A64-42AE-A399-E53E806DDDFFQ24794673-F0F9EA66-E6D4-46C9-8065-05FE0DD25448Q24816368-608EEB68-7E57-48CC-BBE6-08767E78F234Q26851367-E3D77C27-652B-46EF-8628-C621C0A91E29Q28166489-BD11B753-8C05-47F0-985A-AF14E2893C64Q28183919-EDD36A7A-66D4-4CFE-9C9E-8AA3B010E308Q28192298-CD0A19BE-ACA7-47D7-9198-A4154620FB56Q28193982-1316675A-0042-4B9F-AD12-AEDA80AD0966Q28194021-4A116D74-E44D-4FEB-B606-ACB68CE30FE9Q28199474-BCFF780F-0D3F-4944-9830-7030D645D137Q28208759-539B055C-BBCB-46E7-B209-8CA8E32E61D6Q28211198-FD6CE6A1-AE6B-4F0D-A655-4BC98A48CB74Q28219116-540D7D96-C796-4DF7-9F72-0DC33DBB9602Q28220382-D9D10851-FBE7-497B-BBFC-84BF68371332Q28220600-B1D3672A-3451-4BAE-BCC2-90C0ED7FD0E8Q28221437-9F2B3D40-5610-4E39-90D4-A6516E29F14EQ33664298-01CF0FB5-67C7-46FA-A571-B059ACA203E6Q33994559-4642D7A0-64AA-47E2-98B0-822F3C33936BQ34389630-B679DA62-C3DC-4E63-9CA2-E827B5E6F792Q34390050-CF5FD657-E8AB-4725-BA6A-3B84904D52C6Q34771381-C47B8040-D945-456B-9C67-99D943673B82Q35232269-A43FE09D-9B09-4E80-AB85-89D53ACE0D0CQ35947855-46DE3EC9-B8C8-4792-AFE3-C1E39073EB57Q36140286-41FFD669-2E33-49FF-B93E-008BFAA8DBF6Q36371688-54FEFE6A-D994-41A6-BF92-9D9B957119B4Q36664802-BE9E7D5F-44A5-42CD-AE6D-558D464A7DE3Q36881941-708C9A55-2547-47F5-8B3C-56FC8A7732E0Q36932221-D40FFC92-10CC-4058-92AA-2B3926427B73Q37167506-E0BD4C5D-BA4D-46C4-B7B2-41A3AA023A11Q37227512-49637B6B-7A1F-410B-BC5E-947EE3F9009EQ37234897-10E222CF-445D-4CB9-B862-4D56E76E3C7AQ37276469-4F8F4BAE-EA26-4707-A72D-BE2322744D95Q37458916-11723426-60C8-45CF-B233-BE8101D2BA7DQ37608580-BB67B6A8-9E72-4D27-9B4C-6BA6D2592367Q37678829-C5D3D578-D63F-49E9-8D9A-C16E133096C1Q37724505-3F481141-207E-4603-AB9F-BB25781F1BD0Q37726989-0FC37F38-3FA3-4E2A-B460-AD68C9A0ACE5Q37752222-ED755509-139B-4BBA-B85B-45695BA20476Q38046968-6FF018D3-C321-453F-86D2-BDD450D55A0BQ38055245-7AF3686B-6A62-4636-86D7-D01BF4468275
P2860
Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Resistance to aspirin in vitro ...... ivity to adenosine diphosphate
@ast
Resistance to aspirin in vitro ...... ivity to adenosine diphosphate
@en
Resistance to aspirin in vitro ...... ivity to adenosine diphosphate
@nl
type
label
Resistance to aspirin in vitro ...... ivity to adenosine diphosphate
@ast
Resistance to aspirin in vitro ...... ivity to adenosine diphosphate
@en
Resistance to aspirin in vitro ...... ivity to adenosine diphosphate
@nl
prefLabel
Resistance to aspirin in vitro ...... ivity to adenosine diphosphate
@ast
Resistance to aspirin in vitro ...... ivity to adenosine diphosphate
@en
Resistance to aspirin in vitro ...... ivity to adenosine diphosphate
@nl
P2093
P1433
P1476
Resistance to aspirin in vitro ...... ivity to adenosine diphosphate
@en
P2093
L Christiaens
P356
10.1016/S0049-3848(02)00210-4
P407
P577
2002-07-15T00:00:00Z